Retinai

RetinAI optimises and simplifies clinics, research and pharmaceutical workflows to improve healthcare. To achieve this goal, the company builds tools to collect, analyze and organize health data, empowering healthcare professionals and patients with automatic image and data analysis supported by advanced machine learning.

Artificial Intelligence (AI) Cloud Computing Health Diagnostics Health Care Information Technology Machine Learning Software

$8M

Latest Funding

Series B

Latest Funding Stage

2024-10-16

Funding Date

42

Employees

Switzerland

Location

Bern, Bern

City & State

Key Contacts
Unlock Contact Information

Upgrade to access founder details

Upgrade Now
Open Positions
View Careers Page
Hiring For
n/a
Unlock Tech Stack Data

Upgrade to access technology insights

Upgrade Now

Similar Startups

Archipelo
Archipelo  Logo

The Archipelo Developer Security Posture Management Platform provides organizations with—the underlying system of record to capture SDLC event data tied to developer actions. Archipelo empowers security, GRC, and engineering teams to proactively identify, triage, and mitigate risks before they impact your business.

Workhelix
Workhelix Logo

Workhelix brings together advanced research and comprehensive data to assess organizations' generative AI opportunities and which tasks can be accelerated with available technology, enabling businesses to navigate the opportunity landscape with data and reports, rather than relying on gut and instinct.

Subscript
Subscript  Logo

Subscript is a platform that allows users to develop, understand, and manage subscription businesses. This enables members to update the database, calculate measures such as ARR, net revenue retention, CAC, LTV, ARPA, and so on, and analyze customer segments.

Eikon Therapeutics
Eikon Therapeutics  Logo

Eikon Therapeutics is a biopharmaceutical company that focuses on developing innovative technologies for drug discovery. The company utilizes advanced live-cell resolution microscopy and engineering to identify and create new therapeutic candidates. Eikon Therapeutics aims to enhance the understanding of biological processes at a cellular level,supporting targeted treatment development.